Health

Tempus AI

FREE

AI precision medicine platform, now publicly traded

New(no reviews yet) 0 views Updated 9/7/2026

Visit Website Affiliate Link

Overview

AI precision medicine platform, now publicly traded

Key Features

Tempus AI analyzes genomic sequencing, medical imaging, and clinical records to identify patterns in cancer care and cardiology, helping physicians make more personalized treatment decisions. It went public on Nasdaq in 2024, giving public markets a direct read on how well AI-driven precision medicine businesses can actually scale and turn a profit.